Skip to main content
Clinical Trials/IRCT20191210045677N1
IRCT20191210045677N1
Recruiting
Phase 3

Evaluation of incidence of metabolic abnormalities in schizophrenic patients treating with olanzapine and sitagliptin in comparison with olanzapine and placebo

Shiraz University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiraz University of Medical Sciences
Enrollment
80
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of schizophrenia based on DSM\-5 criteria and clinical interview
  • treating with olanzapine

Exclusion Criteria

  • Diagnosis of other mental disorders
  • Major medical problems(cardiovascular,pulmonary,gasterointestinal,renal)
  • Substance use
  • Premorbid or comorbid metabolic abnormalities(obesity,diabetes,hypertension,hyperlipidemia)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A study to assess the occurrence of metabolic diseases associated with the use of antipsychotic drugs in Korean schizophrenia patients based on the national health insurance database
KCT0003568Kyung Hee University Hospital10,000
Not yet recruiting
Not Applicable
Association of metabolic abnormalities in primary frozen shoulder
CTRI/2024/01/061277Kasturba Medical College
Completed
Not Applicable
Effect of the modified Mediterranean diet for prevention of metabolic syndrome in patients undergoing liver transplantatioCondition 1: Metabolic Syndrome. Condition 2: Metabolic Syndrome. Condition 3: Metabolic Syndrome. Condition 4: Metabolic Syndrome. Condition 5: Metabolic Syndrome.Pure hyperglyceridaemiaEssential (primary) hypertensionElevated blood glucose levelAbnormal weight gainLipoprotein deficiency
IRCT2015012720841N1Vice-Chancellery of Research and Technology150
Completed
Phase 2
Evaluation of the clinical and metabolic outcomes of pharmacotherapy based total parental nutrition support in adult patients undergoing bone marrow transplantatioParental nutrition support in bone marrow transplantation.Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
IRCT201203041030N9Hematology-Oncology & SCT Research Center60
Recruiting
Not Applicable
Clinical investigation and analysis for metabolism improving effects of highly functional rice "AMIROMOCHI"
JPRN-UMIN000015560Faculty of Medicine, University of the Ryukyus, Second Department of Internal Medicine20